# Detection of Group A β-Hemolytic Streptococci in Oral Samples

> **NCT05223634** · — · UNKNOWN · sponsor: **Hero Scientific** · enrollment: 300 (estimated)

## Conditions studied

- Group A β-Hemolytic Streptococci

## Interventions

- **OTHER:** Collection of oral and/or nasal samples

## Key facts

- **NCT ID:** NCT05223634
- **Lead sponsor:** Hero Scientific
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-18
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05223634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05223634, "Detection of Group A β-Hemolytic Streptococci in Oral Samples". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05223634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*